Controversy: Atrial fibrillation ablation should be performed in patients with HFpEF
Abstract The role of atrial fibrillation (AF) ablation in the management of heart failure with preserved ejection fraction (HFpEF) remains an under investigated issue with no robust clinical trials data. This controversy reviews the evidence for and against AF ablation in this complex condition from two different perspectives reviewing mechanistic and observational evidence aswell as proposing future directions for research in the field.
Authors
- Pier David Lambiase (ORCID: https://orcid.org/0000-0002-9055-9267)
- Luigi Di Biase
- Matthew M Y Lee
- Fengwei Zou
- Carolyn S.P. Lam
Institutions
- Montefiore Medical Center (US)
- National University of Singapore (SG)
- British Heart Foundation (GB)
- Baim Institute for Clinical Research (US)
- Duke-NUS Medical School (SG)
- National Heart Centre Singapore (SG)
- University College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- EP Europace
- Published
- 2026-11-04
- DOI
- https://doi.org/10.1093/europace/euag313
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00